Regeneron Pharmaceuticals put up a commanding fourth-quarter beat on Friday, helped by Praluent. REGN stock is trading at an all-time high.

The post The Surprising Sources Of Regeneron’s Fourth-Quarter Beat As Shares Hit Another Record High appeared first on Investor’s Business Daily.